AdaptHealth (AHCO)

• Market cap: $989M
• 1 day: -5.91%
• 5 days: -16.70%
• 1 month: -26.63%
• 3 months: -30.19%
• 6 months: -32.44%
• Year to date: -24.43%
• 1 year: -23.65%
• 5 years: -50.84%
• 10 years: -24.43%
• Sector: Healthcare
• Industry: Medical Devices

About: AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

Employees: 10,500

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

42% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 59

24% more call options, than puts

Call options by funds: $79.5M | Put options by funds: $63.9M

5.45% more ownership

Funds ownership: 91.92% [Q3] → 97.37% (+5.45%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 2 (+0) [Q4]

8% less funds holding

Funds holding: 216 [Q3] → 199 (-17) [Q4]

10% less capital invested

Capital invested by funds: $1.39B [Q3] → $1.25B (-$141M) [Q4]

48% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 31

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $11 50% upside
• Avg. target: $13.80 88% upside
• High target: $16 118% upside

5 analyst ratings

• positive: 5 100%
• neutral: 0 0%
• negative: 0 0%

Baird Eric Coldwell 38% 1-year accuracy 12 / 32 met price target	118% upside $16	Outperform Maintained	27 Feb 2025
Canaccord Genuity Richard Close 32% 1-year accuracy 8 / 25 met price target	91% upside $14	Buy Maintained	26 Feb 2025
RBC Capital Ben Hendrix 37% 1-year accuracy 24 / 65 met price target	91% upside $14	Outperform Maintained	26 Feb 2025
Truist Securities David Macdonald 60% 1-year accuracy 60 / 100 met price target	91% upside $14	Buy Maintained	26 Feb 2025
UBS Whit Mayo 19% 1-year accuracy 3 / 16 met price target	50% upside $11	Buy Maintained	13 Feb 2025